Study Of Sunitinib With Capecitabine In Breast Cancer

NCT00662025 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced/Metastatic Breast Cancer

Interventions

DRUG: Capecitabine
DRUG: Sunitinib

Sponsor

Pfizer